Literature DB >> 29069930

Long-term health effects of chemical warfare agents on children following a single heavy exposure.

J M Talabani1, A I Ali2, A M Kadir3, R Rashid2, F Samin2, D Greenwood4, Awm Hay5.   

Abstract

In the 1980s, villages in the Kurdistan region of Iraq were exposed to chemical weapons (CWs), which killed and injured thousands of civilians. There has been no clinical assessment of the long-term effects of CWs exposure on those injured. We report the first such evaluation of CW effects on long-term health of children. Patients from the CW-exposed areas were interviewed to assess previous and current clinical history and underwent clinical examination. The status of organs known to be targets of CWs, including skin, eyes, respiratory and neuromuscular systems, was assessed. Children of similar age and social background, but with no history of CW exposure, were selected as a control population. Results showed that 70% of children in the CWs group had chronic health problems in contrast to 3.3% in the unexposed group ( p < 0.0001). Fifty-five per cent of the CW-exposed group had long-term visual impairment but none in the unexposed population. Thirty-six per cent of the CW-exposed group had chronic dermatological conditions compared with 0.8% of the unexposed group ( p < 0.0001), 31% of the CWs group had neurological sequelae compared with 0.4% of the unexposed group ( p < 0.0001) and 51% of the CWs group had long-term respiratory problems compared with 1.5% of the unexposed group ( p < 0.0001). Respiratory complaints including asthma, chronic bronchitis and bronchiectasis were particularly common. Our study suggests that CWs used were probably a combination of sulphur mustard and organophosphate nerve agents. Results also indicate that the prevalence of acute and chronic health problems following exposure to CW agents appear to be higher in children compared with reported data in adults.

Entities:  

Keywords:  Chemical weapons; Kurds; chronic health effects; nerve agents; paediatrics; sulphur mustard

Mesh:

Substances:

Year:  2017        PMID: 29069930     DOI: 10.1177/0960327117734620

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  6 in total

Review 1.  Acute and long-term consequences of exposure to organophosphate nerve agents in humans.

Authors:  Taiza H Figueiredo; James P Apland; Maria F M Braga; Ann M Marini
Journal:  Epilepsia       Date:  2018-08-29       Impact factor: 5.864

2.  Rapid quantification of two chemical nerve agent metabolites in serum.

Authors:  Michael Kammer; Amanda Kussrow; Melissa D Carter; Samantha L Isenberg; Rudolph C Johnson; Robert H Batchelor; George W Jackson; Darryl J Bornhop
Journal:  Biosens Bioelectron       Date:  2019-01-31       Impact factor: 10.618

3.  Long-Term Anxiety-like Behavior and Microbiota Changes Induced in Mice by Sublethal Doses of Acute Sarin Surrogate Exposure.

Authors:  Sabine François; Stanislas Mondot; Quentin Gerard; Rosalie Bel; Julie Knoertzer; Asma Berriche; Sophie Cavallero; Rachid Baati; Cyrille Orset; Gregory Dal Bo; Karine Thibault
Journal:  Biomedicines       Date:  2022-05-18

4.  Health perspectives among Halabja's civilian survivors of sulfur mustard exposure with respiratory symptoms-A qualitative study.

Authors:  Faraidoun Moradi; Mia Söderberg; Fazil Moradi; Bledar Daka; Anna-Carin Olin; Mona Lärstad
Journal:  PLoS One       Date:  2019-06-21       Impact factor: 3.240

Review 5.  Acetylcholinesterase: The "Hub" for Neurodegenerative Diseases and Chemical Weapons Convention.

Authors:  Samir F de A Cavalcante; Alessandro B C Simas; Marcos C Barcellos; Victor G M de Oliveira; Roberto B Sousa; Paulo A de M Cabral; Kamil Kuča; Tanos C C França
Journal:  Biomolecules       Date:  2020-03-07

6.  Gendered lived experiences of marriage and family following exposure to chemical warfare agents: content analysis of qualitative interviews with survivors in Halabja, Kurdistan-Iraq.

Authors:  Faraidoun Moradi; Fazil Moradi; Mia Söderberg; Anna-Carin Olin; Mona Lärstad
Journal:  BMJ Open       Date:  2020-10-14       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.